ALPINE IMMUNE SCIENCES, INC. Business Finance Contracts & Agreements
39 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Exchange Agreements (1)
- Investor Rights Agreements (1)
- Loan Agreements (2)
- Purchase Agreements (3)
- Registration Rights Agreements (3)
- Stock Agreements (15)
- Underwriting Agreements (3)
- Warrant Agreements (10)
- Description of Capital Stock (Filed With SEC on March 20, 2024)
- Form of Stand-Alone Inducement Stock Option Grant between the Registrant and (Filed With SEC on November 14, 2023)
- Form of Stand-Alone Inducement Stock Option Grant between the Registrant and (Filed With SEC on November 14, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on November 8, 2023)
- Underwriting Agreement, dated (Filed With SEC on November 8, 2023)
- Description of Capital Stock (Filed With SEC on March 23, 2023)
- Form of Stand-Alone Inducement Stock Option Grant between the Company and Andrew Sandler (Filed With SEC on November 14, 2022)
- Underwriting Agreement, dated September 20, 2022, by and among Alpine Immune Sciences, Inc. and Morgan Stanley & Co. LLC, SVB Securities LLC and Cowen and Company, LLC, as... (Filed With SEC on September 21, 2022)
- Stock Purchase Agreement, dated December 15, 2021 by and between Alpine Immune Sciences, Inc. and Horizon Therapeutics Ireland DAC (Filed With SEC on March 17, 2022)
- Exchange Agreement, dated September 14, 2021, by and between the Company and Frazier Life Sciences VIII, L.P (Filed With SEC on September 15, 2021)
- Form of Prefunded Warrant to Purchase Common Stock (Filed With SEC on September 15, 2021)
- Registration Rights Agreement, dated September (Filed With SEC on September 15, 2021)
- Securities Purchase Agreement, dated September (Filed With SEC on September 15, 2021)
- Form of Stand-Alone Inducement Stock Option Grant between the Company and Zelanna Goldberg (Filed With SEC on August 10, 2021)
- Description of Capital Stock (Filed With SEC on March 18, 2021)
- Form of Prefunded Warrant to Purchase Common Stock (Filed With SEC on July 24, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on July 24, 2020)
- Registration Rights Agreement, dated July 24, 2020, by and among the Company and the Purchasers (Filed With SEC on July 24, 2020)
- Securities Purchase Agreement, dated July 24, 2020, by and among the Company and the Purchasers (Filed With SEC on July 24, 2020)
- Description of Capital Stock (Filed With SEC on March 30, 2020)
- Amended and Restated Loan and Security Agreement, dated August 26, 2019, by and among Alpine Immune Sciences, Inc., AIS Operating Co., Inc. and Silicon Valley Bank (Filed With SEC on August 28, 2019)
- Warrant to Purchase Common Stock, dated August 26, 2019, by and between Alpine Immune Sciences, Inc. and Silicon Valley Bank (Filed With SEC on August 28, 2019)
- Securities Purchase Agreement, dated January 15, 2019, by and among the Company and the Purchasers (Filed With SEC on January 16, 2019)
- Form of Warrant to Purchase Common Stock (Filed With SEC on January 16, 2019)
- Registration Rights Agreement, dated January 15, 2019, by and among the Company and the Purchasers (Filed With SEC on January 16, 2019)
- Form of Stand-Alone Inducement Stock Option Grant (Filed With SEC on August 6, 2018)
- Equity Distribution Agreement, dated as of June 11, 2018, between Alpine Immune Sciences, Inc. and Piper Jaffray & Co (Filed With SEC on June 11, 2018)
- Loan and Security Agreement, dated December 16, 2016, by and among Alpine Immune Sciences, Inc. and Silicon Valley Bank (Filed With SEC on March 28, 2018)
- Form of Warrant to Purchase Shares of Common Stock issued to certain service providers on April 12, 2017 pursuant to the Amended and Restated 2015 Stock Plan, as amended (Filed With SEC on March 28, 2018)
- Warrant to Purchase Shares, dated December 16, 2016, by and between Alpine Immune Sciences, Inc. and Silicon Valley Bank (Filed With SEC on March 28, 2018)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on March 28, 2018)
- NOTICE OF RESTRICTED STOCK UNIT INDUCEMENT GRANT NIVALIS THERAPEUTICS, INC. (Filed With SEC on May 3, 2016)
- NOTICE OF INDUCEMENT STOCK OPTION GRANT NIVALIS THERAPEUTICS, INC. (Filed With SEC on May 3, 2016)
- [Number of Shares] Nivalis Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 3, 2015)
- NIVALIS THERAPEUTICS, INC. EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 13, 2015)
- SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 13, 2015)
- N30 PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 13, 2015)
- N30 PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 13, 2015)
- NIVALIS THERAPEUTICS, INC. a Delaware Corporation Incorporated on July 31, 2012 Common Stock Par Value: $0.001 (Filed With SEC on May 13, 2015)
